Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Azitra, Inc.
Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors
August 22, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome
August 20, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates
August 12, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering
July 25, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Announces Pricing of $10.0 Million Public Offering
July 23, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents
July 23, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Announces Reverse Stock Split
June 27, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention
May 31, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting
May 17, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
May 10, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates
May 09, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting
April 22, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024
April 18, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates
March 15, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Announces Closing of Public Offering
February 16, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Announces Pricing of Public Offering
February 13, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US
January 16, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference
January 03, 2024
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates
November 14, 2023
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra to Present at the ThinkEquity Conference
October 16, 2023
From
Azitra, Inc.
Via
Business Wire
Tickers
AZTR
Azitra Appoints Francisco Salva as Chief Executive Officer
May 04, 2021
From
Azitra, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.